Anne Whitaker Aerami's guest appearances

Anne Whitaker Aerami

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Aerami Therapeutics

Anne Whitaker

Anne Whitaker, CEO, Aerami Therapeutics talks about imatinib their inhaled treatment for the rare disease pulmonary arterial hypertension which could potentially be the first therapy on the market to actually reverse the disease.  First approved as a cancer therapy, imatinib stops the progression of the stiffening and thickening of the blood vessels in the lungs and is delivered using a breath-activated, Bluetooth enabled, hand-held nebulizer device delivering the drug centrally in the lung and in the peripheral area. @aeramiTx #inhaledtherapies #RespiratoryDiseases #PulmonaryArterialHypertension #PAH #imatinib Aerami.com Download the transcript here

Anne Whitaker, CEO, Aerami Therapeutics talks about imatinib their inhaled treatment for the rare disease pulmonary arterial hypertension which could potentially be the first therapy on the market to actually reverse the disease.  First approved as a cancer therapy, imatinib stops the progression of the stiffening and thickening of the blood vessels in the lungs and is delivered using a breath-activated, Bluetooth enabled, hand-held nebulizer device delivering the drug centrally in the lung and in the peripheral area. @aeramiTx #inhaledtherapies #RespiratoryDiseases #PulmonaryArterialHypertension #PAH #imatinib <a rel="noopener">Aerami.com</a> <a href="http://empoweredpatientradio.com/next-generation-inhaled-therapies-for-severe-respiratory-diseases-with-anne-whitaker-aerami-therapeutics-transcript-0" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Next Generation Inhaled Therapies for Severe Respiratory Diseases with Anne Whitaker Aerami Therapeutics